Figure 6B shows that the IFN-γ-producing CD3+ T cells were significantly increased when cultured with NR-S1K cells from the in vivo rapamycin-treated mice compared with NR-S1K cells from the control mice, suggesting that the tumor cells treated with rapamycin had the capacity to stimulate T cells. This evidence concerns the gene IFNG and neoplasm.